The Cost-Effectiveness of Corticosteroids for the Treatment of Community-Acquired Pneumonia-Reference-Cited by-同舟云学术

The Cost-Effectiveness of Corticosteroids for the Treatment of Community-Acquired Pneumonia

Published:2019-04 Issue:4 Volume:155 Page:787-794
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Pliakos Elina Eleftheria,Andreatos Nikolaos,Tansarli Giannoula S.,Ziakas Panayiotis D.,Mylonakis Eleftherios

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference48 articles.

1. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged >/=50 years;Sato;Appl Health Econ Health Policy,2013

2. Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization;Mikami;Lung,2007

3. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia;Stahl;Arch Intern Med,1999

4. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia;Gleason;Arch Intern Med,1999

5. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia;Ramirez;Arch Intern Med,2001

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Executive Summary: Guidelines on Use of Corticosteroids in Critically Ill Patients With Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia Focused Update 2024;Critical Care Medicine;2024-01-19

2. 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia;Critical Care Medicine;2024-01-19

3. Corticosteroids for the treatment of respiratory infection by Mycoplasma pneumoniae in children: A cost‐utility analysis;Pediatric Pulmonology;2023-07-11

4. Severe community-acquired pneumonia;EUR RESPIR REV;2022

5. Severe community-acquired pneumonia;European Respiratory Review;2022-12-14